Horse antibodies show promise against severe COVID-19 in clinical trial
Disease control
Completed
This study tested a treatment called INM005, made from antibodies produced in horses, for adults hospitalized with moderate to severe COVID-19. The goal was to see if it could help patients recover faster, measured by improvement on a standard health scale 28 days after treatment…
Phase: PHASE2, PHASE3 • Sponsor: Inmunova S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC